+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour



Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour



Zhonghua Fu Chan Ke Za Zhi 34(2): 97-100



To evaluate the response rate and toxicity of etopside, methotrexate, kengshengmycin, cyclophosphamide and vincristine (EMA/CO) regimen for women with chemorefractory gestational trophoblastic tumour. Fifty-one patients with chemorefractory gestational trophoblastic tumour were treated by EMA/CO regimen. Operative excision and (or) selective arterial infusion as adjuncts to chemotherapy were performed in a selected subset of patients. The response and toxicity were assessed after treatment. Fifty-one patients received 352 cycles of the study regimen. The median number of courses for each patient was 6.9. Thirty-three cases (64.7%) achieved a complete remission while 14 patients (27.5%) had a partial remission, 4 cases showed nonresponse. Two (6.7%) of 30 complete responders developed recurrences. The main complications for EMA/CO chemotherapy were myelosuppression and gastrointestinal symptoms. The EMA/CO regimen is an effective treatment for chemorefractory gestational trophoblastic tumour, and the chemotherapeutic results can be further improved while combined with arterial infusion chemotherapy and surgery in the selected patients.

(PDF emailed within 1 workday: $29.90)

Accession: 046676631

Download citation: RISBibTeXText

PMID: 11263207


Related references

Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour. Zhonghua Fu Chan Ke Za Zhi 40(2): 79-82, 2005

EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. Journal of Reproductive Medicine 49(6): 443-446, 2004

Tumour vascularity assessed using Doppler ultrasound predicts the risk of resistance to methotrexate chemotherapy in gestational trophoblastic tumours. British Journal of Cancer 85(Supplement 1): 26, July, 2001

Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia. Zhonghua Fu Chan Ke Za Zhi 42(9): 595-599, 2007

Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy. International Journal of Gynecological Cancer 26(4): 790-795, 2016

The role of methotrexate in the chemotherapy of gestational trophoblastic neoplasms. Advances in Experimental Medicine and Biology 176: 343-354, 1984

Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. Journal of Clinical Oncology 18(4): 854-859, 2000

Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 25(4): 414-417, 2003

The purpose of methotrexate saturation test in chemotherapy of gestational trophoblastic disease. Journal of Catholic Medical College 44(1): 213-222, 1991

Salvage surgery for chemorefractory gestational trophoblastic disease. Journal of Clinical Oncology 12(12): 2737-2742, 1994

Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Gynecologic Oncology 52(1): 114-115, 1994

Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. American Journal of Obstetrics & Gynecology 172(2 PART 1): 574-579, 1995

Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. Gynecologic Oncology 116(1): 3-9, 2009

Combination chemotherapy for high-risk gestational trophoblastic tumour. Cochrane Database of Systematic Reviews (): Cd005196-Cd005196, 2009

Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecologic Oncology 78(1): 28-31, 2000